A low daily dose of aspirin can reduce the risk for cardiovascular events, and recent data also show that it might reduce cancer-specific mortality.
However, researchers from the American Cancer Society (ACS) caution that the actual rate of risk reduction is still unclear, and that it is too early to make recommendations.
A recent pooled analysis of 8 randomized trials of daily aspirin for the prevention of vascular events reported a dramatic 34% reduction in overall cancer mortality after 5 years. The effects were similar and independent of dose, sex, and smoking (Lancet. 2011;377:31-41).
However, a study from the ACS, presented here at the Tenth Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research, found that although aspirin use was associated with less cancer mortality, the reduction in cancer mortality was much smaller than that seen in the pooled analysis (....)
The associations between daily aspirin use and cancer mortality appeared to be similar for low-dose and adult-strength aspirin.
While the researchers work out the protocols for heart disease and cancer, I will continue on the daily baby aspirin regimen as recommended by my physicians. There is a REAL benefit for avoiding cardiovascular events and there is really NO reason not to continue.
Please check with your physician before embarking upon or stopping aspirin therapy.